{
  "id": "knowledgator/events-focused-biotech-news-classification-dataset",
  "id_no": 4367005,
  "datasetSlugNullable": "events-focused-biotech-news-classification-dataset",
  "ownerUserNullable": "knowledgator",
  "usabilityRatingNullable": 0.6470588235294118,
  "titleNullable": "Events-focused biotech news classification dataset",
  "subtitleNullable": "",
  "descriptionNullable": "Classes\nThe dataset consists of 31 classes, including None values.\n\n| Category                             | Description |\n|--------------------------------------|-------------|\n| Alliance & Partnership               | Forming an alliance or partnership. |\n| Article Publication                  | Publishing an article. |\n| Clinical Trial Sponsorship           | Sponsoring or participating in a clinical trial. |\n| Closing                              | Shutting down a facility/office/division or ceasing an initiative. |\n| Company Description                  | Describing or profiling the company. |\n| Department Establishment             | Establishing a new department or division. |\n| Event Organisation                   | Organizing or participating in an event. |\n| Event Organization                   | Organizing or participating in an event like a conference, exhibition, etc. |\n| Executive Appointment                | Appointing a new executive. |\n| Executive Statement                  | A statement or quote from an executive of a company. |\n| Expanding Geography                  | Expanding into new geographical areas. |\n| Expanding Industry                   | Expanding into new industries or markets. |\n| Foundation                           | Establishing a new charitable foundation. |\n| Funding Round                        | Raising a new round of funding. |\n| Hiring                               | Announcing new hires or appointments at the company. |\n| Investment in Public Company         | Making an investment in a public company. |\n| IPO Exit                             | Having an initial public offering or acquisition exit. |\n| M&A                                  | Mergers, acquisitions, or divestitures. |\n| New Initiatives & Programs           | Announcing new initiatives or programs. |\n| New Initiatives or Programs          | Announcing new initiatives, programs, or campaigns. |\n| None                                 | No label. |\n| Participation in an Event            | Participating in an industry event, conference, etc. |\n| Partnerships & Alliances             | Forming partnerships or strategic alliances with other companies. |\n| Patent Publication                   | Publication of a new patent filing. |\n| Product Launching & Presentation     | Launching or unveiling a new product. |\n| Product Updates                      | Announcing updates or new versions of existing products. |\n| Regulatory Approval                  | Getting approval from regulatory bodies for products, services, trials, etc. |\n| Service & Product Providing          | Launching or expanding products or services. |\n| Subsidiary Establishment             | Establishing a new subsidiary company. |\n| Support & Philanthropy               | Philanthropic activities or donations. |\n| Other                                | Other events that don't fit into defined categories. |\n\n\n**Benchmark**\nWe trained various models with binary-cross entropy loss and evaluated them on the test set.\n\n| Model            | Accuracy | F1    | Precision | Recall |\n|------------------|----------|-------|-----------|--------|\n| DeBERTa-small    | 96.58    | 67.69 | 74.18     | 62.19  |\n| DeBERTa-base     | 96.60    | 67.55 | 74.81     | 61.58  |\n| DeBERTa-large    | 96.99    | 74.07 | 73.46     | 74.69  |\n| SciBERT-uncased  | 96.57    | 68.07 | 73.07     | 63.71  |\n| Flan-T5-base     | 96.85    | 71.10 | 75.71     | 67.07  |\n\nRecommended reading:\nCheck the general overview of the dataset on Medium - [Finally, a decent multi-label classification benchmark is created: a prominent zero-shot dataset](https://medium.com/p/4d90c9e1c718).\n\nTry to train your model on the dataset - [Multi-Label Classification Model From Scratch: Step-by-Step Tutorial](https://huggingface.co/blog/Valerii-Knowledgator/multi-label-classification)\n\n**Feedback**\nWe value your input! Share your feedback and suggestions to help us improve our models and datasets. [Fill out the feedback form](https://docs.google.com/forms/d/e/1FAIpQLSdVTGRCD88MPX56lQFT0IdThkYdriEHff1f7wSI9sSMEbo3gg/viewform)\n\n**Join Our Discord\n**Connect with our community on Discord for news, support, and discussion about our models and datasets. [Join Discord](https://discord.gg/dkyeAgs9DG)\n",
  "datasetId": 4367005,
  "datasetSlug": "events-focused-biotech-news-classification-dataset",
  "hasDatasetSlug": true,
  "ownerUser": "knowledgator",
  "hasOwnerUser": true,
  "usabilityRating": 0.6470588235294118,
  "hasUsabilityRating": true,
  "totalViews": 96,
  "totalVotes": 1,
  "totalDownloads": 21,
  "title": "Events-focused biotech news classification dataset",
  "hasTitle": true,
  "subtitle": "",
  "hasSubtitle": true,
  "description": "Classes\nThe dataset consists of 31 classes, including None values.\n\n| Category                             | Description |\n|--------------------------------------|-------------|\n| Alliance & Partnership               | Forming an alliance or partnership. |\n| Article Publication                  | Publishing an article. |\n| Clinical Trial Sponsorship           | Sponsoring or participating in a clinical trial. |\n| Closing                              | Shutting down a facility/office/division or ceasing an initiative. |\n| Company Description                  | Describing or profiling the company. |\n| Department Establishment             | Establishing a new department or division. |\n| Event Organisation                   | Organizing or participating in an event. |\n| Event Organization                   | Organizing or participating in an event like a conference, exhibition, etc. |\n| Executive Appointment                | Appointing a new executive. |\n| Executive Statement                  | A statement or quote from an executive of a company. |\n| Expanding Geography                  | Expanding into new geographical areas. |\n| Expanding Industry                   | Expanding into new industries or markets. |\n| Foundation                           | Establishing a new charitable foundation. |\n| Funding Round                        | Raising a new round of funding. |\n| Hiring                               | Announcing new hires or appointments at the company. |\n| Investment in Public Company         | Making an investment in a public company. |\n| IPO Exit                             | Having an initial public offering or acquisition exit. |\n| M&A                                  | Mergers, acquisitions, or divestitures. |\n| New Initiatives & Programs           | Announcing new initiatives or programs. |\n| New Initiatives or Programs          | Announcing new initiatives, programs, or campaigns. |\n| None                                 | No label. |\n| Participation in an Event            | Participating in an industry event, conference, etc. |\n| Partnerships & Alliances             | Forming partnerships or strategic alliances with other companies. |\n| Patent Publication                   | Publication of a new patent filing. |\n| Product Launching & Presentation     | Launching or unveiling a new product. |\n| Product Updates                      | Announcing updates or new versions of existing products. |\n| Regulatory Approval                  | Getting approval from regulatory bodies for products, services, trials, etc. |\n| Service & Product Providing          | Launching or expanding products or services. |\n| Subsidiary Establishment             | Establishing a new subsidiary company. |\n| Support & Philanthropy               | Philanthropic activities or donations. |\n| Other                                | Other events that don't fit into defined categories. |\n\n\n**Benchmark**\nWe trained various models with binary-cross entropy loss and evaluated them on the test set.\n\n| Model            | Accuracy | F1    | Precision | Recall |\n|------------------|----------|-------|-----------|--------|\n| DeBERTa-small    | 96.58    | 67.69 | 74.18     | 62.19  |\n| DeBERTa-base     | 96.60    | 67.55 | 74.81     | 61.58  |\n| DeBERTa-large    | 96.99    | 74.07 | 73.46     | 74.69  |\n| SciBERT-uncased  | 96.57    | 68.07 | 73.07     | 63.71  |\n| Flan-T5-base     | 96.85    | 71.10 | 75.71     | 67.07  |\n\nRecommended reading:\nCheck the general overview of the dataset on Medium - [Finally, a decent multi-label classification benchmark is created: a prominent zero-shot dataset](https://medium.com/p/4d90c9e1c718).\n\nTry to train your model on the dataset - [Multi-Label Classification Model From Scratch: Step-by-Step Tutorial](https://huggingface.co/blog/Valerii-Knowledgator/multi-label-classification)\n\n**Feedback**\nWe value your input! Share your feedback and suggestions to help us improve our models and datasets. [Fill out the feedback form](https://docs.google.com/forms/d/e/1FAIpQLSdVTGRCD88MPX56lQFT0IdThkYdriEHff1f7wSI9sSMEbo3gg/viewform)\n\n**Join Our Discord\n**Connect with our community on Discord for news, support, and discussion about our models and datasets. [Join Discord](https://discord.gg/dkyeAgs9DG)\n",
  "hasDescription": true,
  "isPrivate": false,
  "keywords": [
    "business"
  ],
  "licenses": [
    {
      "nameNullable": "other",
      "name": "other",
      "hasName": true
    }
  ],
  "collaborators": [],
  "data": []
}